Patent US4615982A successfully refreshed from Google Patents.
US4615982A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Fecal occult blood test
Assignee: Litmus Concepts Inc
•
Filing: 1984-12-11
•
Granted: 1986-10-07
•
Expires: 2004-12-11
Abstract
Abstract Fecal occult blood tests of enhanced sensitivity and specificity are provided by employing (1) a developer composition comprising a solution of a hydroperoxide in a solvent comprising at least about 50% by volume of a solvent for iron protoporphyrins such as dimethyl sulfoxide and/or (2) a solid test matrix comprising a solid support impregnated with a leuco dye and a hemoprotein solubilizing agent. Test results may be further improved by incorporating plant peroxidase inhibitors, iron/copper chelating agents and buffers in the developer and/or test matrix.
Inventors
- 👤 Paul J. Lawrence
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 13:37
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/72; G01N33/721; G01N33/725; C; C12; C12Q; C12Q1/00; C12Q1/26; C12Q1/28; C12Q2326/00; C12Q2326/30; Y; Y10; Y10S; Y10S436/00; Y10S436/904
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
56 words
In a fecal occult blood test wherein a fecal specimen is placed on a solid test matrix having a leuco dye impregnated therein and a hydroperoxide developer solution is subsequently placed on the matrix, the improvement comprising applying as the hydroperoxide developer solution a solution whose solvent comprises at least 50% by volume of dimethyl sulfoxide.
Claim 2
Dependent Claim
56 words
In a fecal occult blood test wherein a fecal specimen is placed on a solid test matrix having a leuco dye impregnated therein and a hydroperoxide developer solution is subsequently placed on the matrix, the improvement comprising applying as the hydroperoxide developer solution a solution whose solvent comprises at least 50% by volume of dimethyl sulfoxide.
Claim 3
Dependent Claim
28 words
The fecal occult blood test of claim 1 wherein the solvent includes a cosolvent selected from the group consisting of water, alkanol, pentane, ethyl acetate, cyclohexane, and acetone.
Claim 4
Dependent Claim
15 words
The fecal occult blood test of claim 1 wherein the solvent is 100% dimethyl sulfoxide.
Claim 5
Dependent Claim
15 words
The fecal occult blood test of claim 1 wherein the hydroperoxide is an organic hydroperoxide.
Claim 6
Dependent Claim
14 words
The fecal occult blood test of claim 1 wherein the hydroperoxide is cumene hydroperoxide.
Claim 7
Dependent Claim
22 words
The fecal occult blood test of claim 1 wherein the dimethyl sulfoxide comprises at least about 75% by volume of the solvent.
Claim 8
Dependent Claim
28 words
The fecal occult blood test of claim 6 wherein the solvent includes a cosolvent selected from the group consisting of water, alkanol, pentane, ethyl acetate, cyclohexane, and acetone.
Claim 9
Dependent Claim
37 words
The fecal occult blood test of claim 1 wherein the solution contains at least one additive selected from the group consisting of hemoprotein solubilizng agents, nitrogenous ligands, iron and copper chelating agents, plant peroxidase inhibitors, and buffers.
Claim 10
Dependent Claim
26 words
The fecal occult blood test of claim 8 wherein the solvent comprises at least about 75% by volume dimethyl sulfoxide and the hydroperoxide is cumene hydroperoxide.
Claim 11
Dependent Claim
21 words
The fecal occult blood test of claim 1 wherein the solid test matrix is additionally impregnated with a hemoprotein solubilizing agent.
Claim 12
Dependent Claim
28 words
The fecal occult blood test of claim 10 wherein the hemoprotein solubilizing agent is capable of converting peroxidatively inactive hemoprotein dimers or aggregrates into peroxidatively active hemoprotein monomers.
Claim 13
Dependent Claim
50 words
The fecal occult blood test of claim 10 wherein the hemoprotein solubilizing agent is a Triton detergent, an alkyltrimethylammonium bromide-based detergent, alkyltrimethylammonium bromide p-toluene sulfonate detergent, a C 10 to C 14 alkali metal salt of a fatty acid, or a C 10 to C 14 alkali metal alkyl sulfate.
Claim 14
Dependent Claim
17 words
The fecal occult blood test of claim 10 wherein the hemoprotein solubilizing agent is sodium dodecyl sulfate.
References Cited (Backward Citations)
US3252762A
Cited
US3917452A
Cited
US3996006A
Cited
US4035150A
Cited
US4071317A
Cited
US4219336A
Cited
US4260393A
Cited
US4251223A
Cited
US4251222A
Cited
US4278439A
Cited
US4333734A
Cited
US4378971A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-10-06 | 1990-04-07 | 1990-10-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-10-06 | 1994-04-07 | 1994-10-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-10-06 | 1998-04-07 | 1998-10-07 | $7700.00 | Window Closed / Lapsed |